Ablexis
Initial Transaction Details
Transaction Date
May 2018
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Equity
Ablexis, LLC created AlivaMab Mouse, a suite of unique, patented next generation transgenic mice, and non-exclusively licenses it as a platform for human therapeutic antibody discovery. Ablexis has license agreements with dozens of companies, including global pharmaceutical companies, public and private biotechnology companies and other entities. Ablexis continues making AlivaMab Mouse available via non-exclusive licenses.
Website